Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Martin Belkin (NPI 1861462129)

Field	Value
Entity Type	Individual
Organization	Martin Belkin
Address	28595 Orchard Lake Rd
City	Farmington Hills
State	MI
ZIP	48334
Taxonomy	Neurology Physician
NPI Enumerated	January 26, 2006

Payer Source	Total Paid
Medicare	$4.7M
Medicaid	$0

Key Findings

Revenue concentration is extreme: the top three Medicare codes (J2350, J2323, J1561) account for 90.9% of this provider's total Medicare revenue, with J2350 contributing $2.3M (47.9%), J2323 contributing $1.3M (27.5%), and J1561 contributing $738.5K (15.6%). This indicates the provider’s financial picture is heavily dependent on a very small set of high-revenue drug administrations rather than broad E/M or diagnostic services.

The code mix indicates an infusion-centric neurology practice focused on high-cost biologic therapies and immune products: J2350 is ocrelizumab, J2323 is natalizumab, J1561 is immune globulin (gamunex-c/gammaked), and J3032 (eptinezumab) also appears on the list. The presence of these specific injectable therapies combined with infusion administration codes suggests in-office or affiliated infusion services delivering disease-modifying MS therapies and IVIG.

Competitive standing is strong for monoclonal antibody infusions: J2350 ranks #4 of 105 providers nationally (97th percentile; notably above typical national volume) and J2323 ranks #2 of 40 providers nationally (97th percentile; notably above typical national volume), marking this provider as a major national-volume contributor for those products. By contrast, J1561 ranks #11 of 180 providers nationally (94th percentile; described as typical, unremarkable volume), so the provider is less dominant for IVIG relative to its leadership in MS monoclonal therapies.

Infusion administration activity is clearly a core operational component: 96365 shows 738 claims and $34.7K revenue and ranks #173 of 8873 providers nationally (98th percentile; notably above typical national volume), while add-on and subsequent infusion administration codes such as 96366 (417 claims, $6.3K; rank #206 of 2976, 93th percentile; typical, unremarkable volume) and 96375 (505 claims, $5.6K; rank #627 of 5191, 88th percentile; typical, unremarkable volume) are also present. Office E/M revenue is a small fraction of the book of business (for example, 99214: 642 claims, $55.2K, 1.2% of Medicare revenue), consistent with a practice model that prioritizes infusion throughput over routine clinic visit revenue.

This provider is effectively single-payer from an observed claims perspective: Total Medicare revenue is $4.7M while Total Medicaid revenue is none (no Medicaid billing on file). The absence of Medicaid billing means payer analyses and contracting assessments should treat the provider as Medicare-focused, with limited or no Medicaid exposure in the available data.

NPI tenure is long: the NPI was enumerated 2006-01-26 (~20 years ago), indicating an established billing history and operational longevity. That tenure supports the plausibility of sustained, specialized infusion operations rather than a transient or newly established practice.

Because the top revenue drivers are high-cost biologic injections that together dominate revenue, payers should expect utilization management, prior authorization, and procurement considerations to be the key levers in managing cost exposure to this provider. The high national ranks and the descriptor notably above typical national volume for J2350 and J2323 reinforce that utilization and supply-cost monitoring will be material.

Diagnostic and procedural neurology codes are present but represent minor revenue share: 95819 has 63 claims and $13K revenue (0.3% of Medicare revenue), 95886 has 41 claims and $3.2K revenue (0.1%), and common clinic E/M codes such as 99213 generate very small revenue (22 claims, $1.3K, 0.0%). This pattern reinforces that the clinical focus is therapeutic infusion services rather than diagnostic testing or high-volume office-based E/M care.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2350	Injection, ocrelizumab, 1 mg	54,000	$40	$2.3M
J2323	Injection, natalizumab, 1 mg	72,300	$20	$1.3M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	19,960	$40	$738.5K
J3032	Injection, eptinezumab-jjmr, 1 mg	18,900	$10	$245.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	640	$90	$55.2K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	740	$50	$34.7K
95819	Electroencephalogram or EEG is a diagnostic test that uses small electrodes attached to the scalp to measure the electrical activity of the brain. In this procedure the provider performs the EEG…	60	$210	$13K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	100	$120	$11.3K
99222	The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or…	110	$100	$10.9K
99232	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or…	170	$60	$10.8K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Martin Belkin — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	1	10	54,000	$40	$2.3M
J2323	1	10	72,300	$20	$1.3M
J1561	1	10	19,960	$40	$745.4K
J3032	1	10	18,900	$10	$239.3K
96413	92	170	120	$100	$16.1K
99232	2,123	6,730	90	$60	$12K
99214	438	15,470	80	$80	$11.4K
95819	34	130	30	$160	$9.5K
95816	85	130	30	$150	$6.7K
99213	12,344	14,810	60	$60	$6.6K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Martin Belkin, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Henry Ford Health Macomb Oakland Hospital	MI	General Acute Care Hospital	$0	$59.2M
Glendale Neurological Associates P C	MI	Neurology Physician	$0	$52.6M
Henry Ford Health Macomb Oakland Hospital	MI	General Acute Care Hospital	$0	$24.8M
Henry Ford Macomb Hospital Corporation	MI	Family Medicine Physician	$0	$9.2M
Srinivas Koneru	MI	Cardiovascular Disease Physician	$984.1K	$0
Herman Kado	MI	Cardiovascular Disease Physician	$771.5K	$0
Luay Sayed	MI	Interventional Cardiology Physician	$593.6K	$0
Aaron Ellenbogen	MI	Neurology Physician	$549.8K	$0
George Dirani	MI	Cardiovascular Disease Physician	$514.1K	$0
Amir Kaki	MI	Interventional Cardiology Physician	$492.4K	$0

Nearby Providers

Other providers in the same ZIP code as Martin Belkin, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Centria Healthcare LLC	MI	Home Health Agency	$0	$591M
Area Agency On Aging 1-b	MI	Case Management Agency	$0	$143.1M
Michigan Healthcare Professionals PC	MI	Internal Medicine Physician	$0	$106.2M
Centria Healthcare	MI	Clinic/Center	$0	$10.1M
Bioprecision Laboratories, Inc.	MI	Clinical Medical Laboratory	$7M	$1.4K
Joshua Grant	MI	Ophthalmology Physician	$1.3M	$0
Michigan Endoscopy Center LLC	MI	Ambulatory Surgical Clinic/Center	$1M	$11.9K
Ronald Bergman	MI	Ophthalmology Physician	$593.7K	$0
John Maarouf	MI	Sports Medicine (Family Medicine) Physician	$419.1K	$0
Jay Levinson	MI	Gastroenterology Physician	$359.6K	$0

Martin Belkin — Billing Profile & Reimbursement Data

Sign up for Martin Belkin — Billing Profile & Reimbursement Data policy alerts

Martin Belkin — Billing Profile & Reimbursement Data

Sign up for Martin Belkin — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References